Skip to main content

Liver and Spleen Stiffness to Predict Portal Hypertension and Its Complications

  • Chapter
  • First Online:
Liver Elastography

Abstract

Portal hypertension is a common syndrome characterized by an increase in portal venous pressure driving life-threatening complications. In advanced chronic liver disease, increased portal venous pressure is one of the hallmarks of progression; in this scenario, portal hypertension is best diagnosed by the invasive measurement of hepatic venous pressure gradient (HVPG). In the last 10 years, ultrasound elastography techniques emerged as valuable non-invasive tools in the field of portal hypertension. It is now possible to identify patients with clinically significant portal hypertension and to guide the selection of patients requiring endoscopy to screen for varices at risk of bleeding using elastography techniques. In addition to liver stiffness measurement (LSM), spleen stiffness measurement (SSM) using transient elastography, point shear wave elastography, and 2D shear-wave elastography have been tested in this setting. This chapter provides an updated summary of the rationale and use of ultrasound elastography to diagnose, stage, and follow up portal hypertension and its complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bosch J, Garcia-Pagán JC, Berzigotti A, Abraldes JG. Measurement of portal pressure and its role in the management of chronic liver disease. Semin Liver Dis. 2006;26(4):348–62.

    Article  PubMed  Google Scholar 

  2. Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–35.

    Article  PubMed  Google Scholar 

  3. Bosch J, Abraldes JG, Berzigotti A, García-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(10):573–82.

    Article  CAS  PubMed  Google Scholar 

  4. Bosch J, Groszmann RJ, Shah VH. Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments. J Hepatol. 2015;62(1 Suppl):S121–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7(2):141–55.

    Article  CAS  PubMed  Google Scholar 

  6. Berzigotti A, Ashkenazi E, Reverter E, Abraldes JG, Bosch J. Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension. Dis Markers. 2011;31(3):129–38.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Groszmann RJ, Garcia-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353(21):2254–61.

    Article  CAS  PubMed  Google Scholar 

  8. Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133(2):481–8.

    Article  CAS  PubMed  Google Scholar 

  9. Hernandez-Gea V, Berzigotti A. Clinical evaluation and prognosis. Dig Dis. 2015;33(4):515–23.

    Article  PubMed  Google Scholar 

  10. Berzigotti A, Reig M, Abraldes JG, Bosch J, Bruix J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology. 2015;61(2):526–36.

    Article  PubMed  Google Scholar 

  11. Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009;50(5):923–8.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol. 2017;67(2):399–411.

    Article  PubMed  Google Scholar 

  13. de Franchis R. Expanding Consensus in Portal Hypertension—Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–52.

    Article  PubMed  Google Scholar 

  14. Bruno S, Zuin M, Crosignani A, Rossi S, Zadra F, Roffi L, et al. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Am J Gastroenterol. 2009;104(5):1147–58.

    Article  PubMed  Google Scholar 

  15. Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32(9):1407–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–31.

    Article  PubMed  Google Scholar 

  17. Qi X, Berzigotti A, Cardenas A, Sarin SK. Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension. Lancet Gastroenterol Hepatol. 2018;3(10):708–19.

    Article  PubMed  Google Scholar 

  18. Llop E, Berzigotti A, Reig M, Erice E, Reverter E, Seijo S, et al. Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors. J Hepatol. 2012;56(1):103–8.

    Article  PubMed  Google Scholar 

  19. Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep. 2017;5(2):79–89.

    Article  Google Scholar 

  20. Silva-Junior G, Baiges A, Turon F, Torres F, Hernández-Gea V, Bosch J, et al. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatology. 2015;62(5):1584–92.

    Article  PubMed  Google Scholar 

  21. La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, et al. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology. 2010;51(6):2108–16.

    Article  PubMed  CAS  Google Scholar 

  22. Lossnitzer D, Steen H, Zahn A, Lehrke S, Weiss C, Weiss KH, et al. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis. J Cardiovasc Magn Reson. 2010;12:47.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45(5):1290–7.

    Article  PubMed  Google Scholar 

  24. Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (Long Version). Ultraschall Med. 2017;38(4):e16–47.

    Article  PubMed  Google Scholar 

  25. Mueller S. Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis. World J Gastroenterol. 2016;22(48):10482.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, et al. Liver ultrasound elastography: an update to the World Federation for Ultrasound in Medicine and Biology guidelines and recommendations. Ultrasound Med Biol. 2018;44(12):2419–40.

    Article  PubMed  Google Scholar 

  27. You MW, Kim KW, Pyo J, Huh J, Kim HJ, Lee SJ, et al. A meta-analysis for the diagnostic performance of transient elastography for clinically significant portal hypertension. Ultrasound Med Biol. 2017;43(1):59–68.

    Article  PubMed  Google Scholar 

  28. Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27(12):1261–8.

    Article  CAS  PubMed  Google Scholar 

  29. Song J, Ma Z, Huang J, Liu S, Luo Y, Lu Q, et al. Comparison of three cut-offs to diagnose clinically significant portal hypertension by liver stiffness in chronic viral liver diseases: a meta-analysis. Eur Radiol. 2018;28(12):5221–30.

    Article  PubMed  Google Scholar 

  30. Pons M, Santos B, Simon-Talero M, Ventura-Cots M, Riveiro-Barciela M, Esteban R, et al. Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals. Therap Adv Gastroenterol. 2017;10(8):619–29.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Mandorfer M, Kozbial K, Schwabl P, Freissmuth C, Schwarzer R, Stern R, et al. Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension. J Hepatol. 2016;65(4):692–9.

    Article  PubMed  Google Scholar 

  32. Rincon D, Ripoll C, Lo Iacono O, Salcedo M, Catalina MV, Alvarez E, et al. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced fibrosis. Am J Gastroenterol. 2006;101(10):2269–74.

    Article  CAS  PubMed  Google Scholar 

  33. Lens S, Alvarado-Tapias E, Marino Z, Londono MC, LLop E, Martinez J, et al. Effects of All-Oral Anti-Viral Therapy on HVPG and systemic hemodynamics in patients with hepatitis C Virus-associated cirrhosis. Gastroenterology. 2017;153(5):1273–83 e1.

    Article  CAS  PubMed  Google Scholar 

  34. Radu C, Stancu O, Sav R, Bugariu A, Suciu A, Grigoras C, et al. Liver stiffness better predicts portal hypertension after HCV eradication. J Gastrointestin Liver Dis. 2018;27(2):204.

    Article  PubMed  Google Scholar 

  35. Salavrakos M, Piessevaux H, Komuta M, Lanthier N, Starkel P. Fibroscan reliably rules out advanced liver fibrosis and significant portal hypertension in alcoholic patients. J Clin Gastroenterol. 2019;53(10):772–8.

    Article  PubMed  Google Scholar 

  36. Song J, Ma Z, Huang J, Luo Y, Zykus R, Kumar A, et al. Reliability of transient elastography-based liver stiffness for diagnosing portal hypertension in patients with alcoholic liver disease: a diagnostic meta-analysis with specific cut-off values. Ultraschall Med. 2019.

    Google Scholar 

  37. Elshaarawy O, Mueller J, Guha IN, Chalmers J, Harris R, Krag A, et al. Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications. JHEP Rep. 2019;1(2):99–106.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Salzl P, Reiberger T, Ferlitsch M, Payer BA, Schwengerer B, Trauner M, et al. Evaluation of portal hypertension and varices by acoustic radiation force impulse imaging of the liver compared to transient elastography and AST to platelet ratio index. Ultraschall Med. 2014;35(6):528–33.

    Article  CAS  PubMed  Google Scholar 

  39. Attia D, Schoenemeier B, Rodt T, Negm AA, Lenzen H, Lankisch TO, et al. Evaluation of liver and spleen stiffness with acoustic radiation force impulse quantification elastography for diagnosing clinically significant portal hypertension. Ultraschall Med. 2015;36(6):603–10.

    Article  CAS  PubMed  Google Scholar 

  40. Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Takabatake H, et al. Portal hypertension in patients with liver cirrhosis: diagnostic accuracy of spleen stiffness. Radiology. 2016;279(2):609–19.

    Article  PubMed  Google Scholar 

  41. Suh CH, Kim KW, Park SH, Lee SS, Kim HS, Tirumani SH, et al. Shear wave elastography as a quantitative biomarker of clinically significant portal hypertension: a systematic review and meta-analysis. Am J Roentgenol. 2018;210(5):W185–W95.

    Article  Google Scholar 

  42. Zhu YL, Ding H, Fu TT, Peng SY, Chen SY, Luo JJ, et al. Portal hypertension in hepatitis B-related cirrhosis: diagnostic accuracy of liver and spleen stiffness by 2-D shear-wave elastography. Hepatol Res. 2019;49(5):540–9.

    Article  PubMed  Google Scholar 

  43. Jansen C, Bogs C, Verlinden W, Thiele M, Moller P, Gortzen J, et al. Algorithm to rule out clinically significant portal hypertension combining Shear-wave elastography of liver and spleen: a prospective multicentre study. Gut. 2016;65(6):1057–8.

    Article  PubMed  Google Scholar 

  44. Jansen C, Bogs C, Verlinden W, Thiele M, Moller P, Gortzen J, et al. Shear-wave elastography of the liver and spleen identifies clinically significant portal hypertension: a prospective multicentre study. Liver Int. 2017;37(3):396–405.

    Article  PubMed  Google Scholar 

  45. Elkrief L, Ronot M, Andrade F, Dioguardi Burgio M, Issoufaly T, Zappa M, et al. Non-invasive evaluation of portal hypertension using shear-wave elastography: analysis of two algorithms combining liver and spleen stiffness in 191 patients with cirrhosis. Aliment Pharmacol Ther. 2018;47(5):621–30.

    Article  CAS  PubMed  Google Scholar 

  46. Dell’era A, Bosch J. Review article: the relevance of portal pressure and other risk factors in acute gastro-oesophageal variceal bleeding. Aliment Pharmacol Ther. 2004;20(Suppl 3):8–15; discussion 6-7.

    Article  PubMed  Google Scholar 

  47. Angeli P, Bernardi M, Villanueva C, Francoz C, Mookerjee RP, Trebicka J, et al. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–60.

    Article  Google Scholar 

  48. Shi KQ, Fan YC, Pan ZZ, Lin XF, Liu WY, Chen YP, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013;33(1):62–71.

    Article  PubMed  Google Scholar 

  49. Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol. 2010;105(6):1382–90.

    Article  PubMed  Google Scholar 

  50. Manatsathit W, Samant H, Kapur S, Ingviya T, Esmadi M, Wijarnpreecha K, et al. Accuracy of liver stiffness, spleen stiffness, and LS-spleen diameter to platelet ratio score in detection of esophageal varices: Systemic review and meta-analysis. J Gastroenterol Hepatol. 2018;33(10):1696–706.

    Article  PubMed  Google Scholar 

  51. Abraldes JG, Bureau C, Stefanescu H, Augustin S, Ney M, Blasco H, et al. Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: the “Anticipate” study. Hepatology. 2016;64(6):2173–84.

    Article  CAS  PubMed  Google Scholar 

  52. Maurice JB, Brodkin E, Arnold F, Navaratnam A, Paine H, Khawar S, et al. Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices. J Hepatol. 2016;65(5):899–905.

    Article  PubMed  Google Scholar 

  53. Marot A, Trepo E, Doerig C, Schoepfer A, Moreno C, Deltenre P. Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding. Liver Int. 2017;37(5):707–16.

    Article  PubMed  Google Scholar 

  54. Pu K, Shi JH, Wang X, Tang Q, Wang XJ, Tang KL, et al. Diagnostic accuracy of transient elastography (FibroScan) in detection of esophageal varices in patients with cirrhosis: a meta-analysis. World J Gastroenterol. 2017;23(2):345–56.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Llop E, Lopez M, de la Revilla J, Fernandez N, Trapero M, Hernandez M, et al. Validation of noninvasive methods to predict the presence of gastroesophageal varices in a cohort of patients with compensated advanced chronic liver disease. J Gastroenterol Hepatol. 2017;32(11):1867–72.

    Article  PubMed  Google Scholar 

  56. Jangouk P, Turco L, De Oliveira A, Schepis F, Villa E, Garcia-Tsao G. Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis. Liver Int. 2017;37(8):1177–83.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Augustin S, Pons M, Maurice JB, Bureau C, Stefanescu H, Ney M, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66(6):1980–8.

    Article  PubMed  Google Scholar 

  58. Petta S, Sebastiani G, Bugianesi E, Vigano M, Wong VW, Berzigotti A, et al. Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis. J Hepatol. 2018;69(4):878–85.

    Article  PubMed  Google Scholar 

  59. Moctezuma-Velazquez C, Saffioti F, Tasayco-Huaman S, Casu S, Mason A, Roccarina D, et al. Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis. Am J Gastroenterol. 2019;114(3):446–52.

    Article  PubMed  Google Scholar 

  60. Lee HA, Kim SU, Seo YS, Lee YS, Kang SH, Jung YK, et al. Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease. Liver Int. 2018;39(6):1071–9.

    Article  Google Scholar 

  61. Bae J, Sinn DH, Kang W, Gwak GY, Choi MS, Paik YH, et al. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. Liver Int. 2018;38(8):1442–8.

    Article  PubMed  Google Scholar 

  62. Thabut D, Bureau C, Layese R, Bourcier V, Hammouche M, Cagnot C, et al. Validation of Baveno VI criteria for screening and surveillance of esophageal varices in patients with compensated cirrhosis and a sustained response to antiviral therapy. Gastroenterology. 2019;156(4):997–1009 e5.

    Article  PubMed  Google Scholar 

  63. Lucchina N, Recaldini C, Macchi M, Molinelli V, Montanari M, Segato S, et al. Point shear wave elastography of the spleen: its role in patients with portal hypertension. Ultrasound Med Biol. 2018;44(4):771–8.

    Article  PubMed  Google Scholar 

  64. Cassinotto C, Charrie A, Mouries A, Lapuyade B, Hiriart J-B, Vergniol J, et al. Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices. Dig Liver Dis. 2015;47(8):695–701.

    Article  PubMed  Google Scholar 

  65. Grgurevic I, Bokun T, Mustapic S, Trkulja V, Heinzl R, Banic M, et al. Real-time two-dimensional shear wave ultrasound elastography of the liver is a reliable predictor of clinical outcomes and the presence of esophageal varices in patients with compensated liver cirrhosis. Croat Med J. 2015;56(5):470–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Kasai Y, Moriyasu F, Saito K, Hara T, Kobayashi Y, Nakamura I, et al. Value of shear wave elastography for predicting hepatocellular carcinoma and esophagogastric varices in patients with chronic liver disease. J Med Ultrason (2001). 2015;42(3):349–55.

    Article  Google Scholar 

  67. Kim TY, Kim TY, Kim Y, Lim S, Jeong WK, Sohn JH. Diagnostic performance of shear wave elastography for predicting esophageal varices in patients with compensated liver cirrhosis. J Ultrasound Med. 2016;35(7):1373–81.

    Article  PubMed  Google Scholar 

  68. Elkrief L, Rautou PE, Ronot M, Lambert S, Dioguardi Burgio M, Francoz C, et al. Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis. Radiology. 2015;275(2):589–98.

    Article  PubMed  Google Scholar 

  69. Stefanescu H, Allegretti G, Salvatore V, Piscaglia F. Bidimensional shear wave ultrasound elastography with supersonic imaging to predict presence of oesophageal varices in cirrhosis. Liver Int. 2017;37(9):1405.

    Article  PubMed  Google Scholar 

  70. Petzold G, Tsaknakis B, Bremer SCB, Knoop RF, G Goetze R, Amanzada A, et al. Evaluation of liver stiffness by 2D-SWE in combination with non-invasive parameters as predictors for esophageal varices in patients with advanced chronic liver disease. Scand J Gastroenterol. 2019;54(3):342–9.

    Article  PubMed  Google Scholar 

  71. Mejias M, Garcia-Pras E, Gallego J, Mendez R, Bosch J, Fernandez M. Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension. J Hepatol. 2010;52(4):529–39.

    Article  CAS  PubMed  Google Scholar 

  72. Pawlus A, Inglot M, Chabowski M, Szymanska K, Inglot M, Patyk M, et al. Shear wave elastography (SWE) of the spleen in patients with hepatitis B and C but without significant liver fibrosis. Br J Radiol. 2016;89(1066):20160423.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Albayrak E, Server S. The relationship of spleen stiffness value measured by shear wave elastography with age, gender, and spleen size in healthy volunteers. J Med Ultrason (2001). 2019;46(2):195–9.

    Article  Google Scholar 

  74. Bastard C, Miette V, Cales P, Stefanescu H, Festi D, Sandrin L. A novel fibroscan examination dedicated to spleen stiffness measurement. Ultrasound Med Biol. 2018;44(8):1616–26.

    Article  PubMed  Google Scholar 

  75. Berzigotti A, Ferraioli G, Bota S, Gilja OH, Dietrich CF. Novel ultrasound-based methods to assess liver disease: the game has just begun. Dig Liver Dis. 2018;50(2):107–12.

    Article  PubMed  Google Scholar 

  76. Cescon M, Colecchia A, Cucchetti A, Peri E, Montrone L, Ercolani G, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg. 2012;256(5):706–12; discussion 12-3.

    Article  PubMed  Google Scholar 

  77. Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, et al. Measurement of spleen stiffness to evaluate portal hypertension and the presence of esophageal varices in patients with HCV-related cirrhosis. Gastroenterology. 2012;143(3):646–54.

    Article  PubMed  Google Scholar 

  78. Mazur R, Celmer M, Silicki J, Holownia D, Pozowski P, Miedzybrodzki K. Clinical applications of spleen ultrasound elastography—a review. J Ultrasonogr. 2018;18(72):37–41.

    Article  Google Scholar 

  79. Wong GLH, Kwok R, Hui AJ, Tse YK, Ho KT, Lo AOS, et al. A new screening strategy for varices by liver and spleen stiffness measurement (LSSM) in cirrhotic patients: a randomized trial. Liver Int. 2018;38(4):636–44.

    Article  PubMed  Google Scholar 

  80. Sharma P, Kirnake V, Tyagi P, Bansal N, Singla V, Kumar A, et al. Spleen stiffness in patients with cirrhosis in predicting esophageal varices. Am J Gastroenterol. 2013;108(7):1101–7.

    Article  PubMed  Google Scholar 

  81. Colecchia A, Ravaioli F, Marasco G, Colli A, Dajti E, Di Biase AR, et al. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol. 2018;69(2):308–17.

    Article  PubMed  Google Scholar 

  82. Sutton H, Fitzpatrick E, Davenport M, Burford C, Alexander E, Dhawan A, et al. Transient elastography measurements of spleen stiffness as a predictor of clinically significant varices in children. J Pediatr Gastroenterol Nutr. 2018;67(4):446–51.

    Article  PubMed  Google Scholar 

  83. Leung VY, Shen J, Wong VW, Abrigo J, Wong GL, Chim AM, et al. Quantitative elastography of liver fibrosis and spleen stiffness in chronic hepatitis B carriers: comparison of shear-wave elastography and transient elastography with liver biopsy correlation. Radiology. 2013;269(3):910–8.

    Article  PubMed  Google Scholar 

  84. Rifai K, Cornberg J, Bahr M, Mederacke I, Potthoff A, Wedemeyer H, et al. ARFI elastography of the spleen is inferior to liver elastography for the detection of portal hypertension. Ultraschall Med. 2011;32(Suppl 2):E24–30.

    Article  PubMed  Google Scholar 

  85. Procopet B, Berzigotti A, Abraldes JG, Turon F, Hernandez-Gea V, Garcia-Pagan JC, et al. Real-time shear-wave elastography: applicability, reliability and accuracy for clinically significant portal hypertension. J Hepatol. 2015;62(5):1068–75.

    Article  PubMed  Google Scholar 

  86. Robic MA, Procopet B, Metivier S, Peron JM, Selves J, Vinel JP, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol. 2011;55(5):1017–24.

    Article  PubMed  Google Scholar 

  87. Merchante N, Rivero-Juarez A, Tellez F, Merino D, Jose Rios-Villegas M, Marquez-Solero M, et al. Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis. Hepatology. 2012;56(1):228–38.

    Article  PubMed  Google Scholar 

  88. Macías J, Camacho A, Von Wichmann MA, López-Cortés LF, Ortega E, Tural C, et al. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients. AIDS. 2013;27(16):2541–9.

    Article  PubMed  Google Scholar 

  89. Wang JH, Chuah SK, Lu SN, Hung CH, Kuo CM, Tai WC, et al. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis. Liver Int. 2014;34(9):1340–8.

    Article  PubMed  Google Scholar 

  90. Kitson MT, Roberts SK, Colman JC, Paul E, Button P, Kemp W. Liver stiffness and the prediction of clinically significant portal hypertension and portal hypertensive complications. Scand J Gastroenterol. 2015;50(4):462–9.

    Article  PubMed  Google Scholar 

  91. Merchante N, Rivero-Juárez A, Téllez F, Merino D, Ríos-Villegas MJ, Ojeda-Burgos G, et al. Liver stiffness predicts variceal bleeding in HIV/HCV-coinfected patients with compensated cirrhosis. AIDS. 2017;31(4):493–500.

    Article  PubMed  Google Scholar 

  92. Singh S, Fujii LL, Murad MH, Wang Z, Asrani SK, Ehman RL, et al. Liver stiffness is associated with risk of decompensation, liver cancer, and death in patients with chronic liver diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013;11(12):1573–84.e2.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Wang J, Li J, Zhou Q, Zhang D, Bi Q, Wu Y, et al. Liver stiffness measurement predicted liver-related events and all-cause mortality: a systematic review and nonlinear dose-response meta-analysis. Hepatol Commun. 2018;2(4):467–76.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Corpechot C, Gaouar F, El Naggar A, Kemgang A, Wendum D, Poupon R, et al. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis. Gastroenterology. 2014;146(4):970–9; quiz e15-6.

    Article  PubMed  Google Scholar 

  95. Vergniol J, Boursier J, Coutzac C, Bertrais S, Foucher J, Angel C, et al. Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C. Hepatology. 2014;60(1):65–76.

    Article  PubMed  Google Scholar 

  96. Kim BK, Park YN, Kim DY, Park JY, Chon CY, Han KH, et al. Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement. Digestion. 2012;85(3):219–27.

    Article  PubMed  Google Scholar 

  97. Mendoza YCS, Murgia G, Chen T, Margini C, Sebastiani G, Berzigotti A. Simple non-invasive surrogates of portal hypertension predict clinical decompensation in overweight/obese patients with cACLD. EASL. 2019;70:e664.

    Google Scholar 

  98. Colecchia A, Colli A, Casazza G, Mandolesi D, Schiumerini R, Reggiani LB, et al. Spleen stiffness measurement can predict clinical complications in compensated HCV-related cirrhosis: a prospective study. J Hepatol. 2014;60(6):1158–64.

    Article  PubMed  Google Scholar 

  99. Grgurevic I, Puljiz Z, Brnic D, Bokun T, Heinzl R, Lukic A, et al. Liver and spleen stiffness and their ratio assessed by real-time two dimensional-shear wave elastography in patients with liver fibrosis and cirrhosis due to chronic viral hepatitis. Eur Radiol. 2015;25(11):3214–21.

    Article  PubMed  Google Scholar 

  100. Takuma Y, Morimoto Y, Takabatake H, Toshikuni N, Tomokuni J, Sahara A, et al. Measurement of spleen stiffness with acoustic radiation force impulse imaging predicts mortality and hepatic decompensation in patients with liver cirrhosis. Clin Gastroenterol Hepatol. 2017;15(11):1782–90.e4.

    Article  PubMed  Google Scholar 

  101. Radu C, Stefanescu H, Procopet B, Lupsor Platon M, Tantau M, Grigorescu M. Is spleen stiffness a predictor of clinical decompensation in cirrhotic patients? J Gastrointestin Liver Dis. 2014;23(2):223–4.

    PubMed  Google Scholar 

  102. Mori K, Arai H, Abe T, Takayama H, Toyoda M, Ueno T, et al. Spleen stiffness correlates with the presence of ascites but not esophageal varices in chronic hepatitis C patients. Biomed Res Int. 2013;2013:857862.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Meister P, Dechene A, Buchter M, Kalsch J, Gerken G, Canbay A, et al. Spleen stiffness differentiates between acute and chronic liver damage and predicts hepatic decompensation. J Clin Gastroenterol. 2019;53(6):457–63.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Buechter M, Kahraman A, Manka P, Gerken G, Jochum C, Canbay A, et al. Spleen and liver stiffness is positively correlated with the risk of esophageal variceal bleeding. Digestion. 2016;94(3):138–44.

    Article  PubMed  Google Scholar 

  105. Wong GL, Liang LY, Kwok R, Hui AJ, Tse YK, Chan HL, et al. Low risk of variceal bleeding in patients with cirrhosis after variceal screening stratified by liver/spleen stiffness. Hepatology. 2019;70(3):971–81.

    Article  PubMed  Google Scholar 

  106. Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology. 2009;49(6):1954–61.

    Article  PubMed  Google Scholar 

  107. Narita Y, Genda T, Tsuzura H, Sato S, Kanemitsu Y, Ishikawa S, et al. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy. J Gastroenterol Hepatol. 2014;29(1):137–43.

    Article  CAS  PubMed  Google Scholar 

  108. Wang HM, Hung CH, Lu SN, Chen CH, Lee CM, Hu TH, et al. Liver stiffness measurement as an alternative to fibrotic stage in risk assessment of hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver Int. 2013;33(5):756–61.

    Article  CAS  PubMed  Google Scholar 

  109. Kim DY, Song KJ, Kim SU, Yoo EJ, Park JY, Ahn SH, et al. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco Targets Ther. 2013;6:1463–9.

    PubMed  PubMed Central  Google Scholar 

  110. Jung KS, Kim SU, Ahn SH, Park YN, Kim DY, Park JY, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology. 2011;53(3):885–94.

    Article  CAS  PubMed  Google Scholar 

  111. Jung KS, Kim SU, Choi GH, Park JY, Park YN, Kim DY, et al. Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan(R)). Ann Surg Oncol. 2012;19(13):4278–86.

    Article  PubMed  Google Scholar 

  112. Marzano A, Tucci A, Chiala C, Saracco GM, Fadda M, Debernardi VW. Liver stiffness-based model for portal hypertension and hepatocellular cancer risk in HBV responsive to antivirals. Minerva Gastroenterol Dietol. 2019;65(1):11–9.

    Article  PubMed  Google Scholar 

  113. Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck-Radosavljevic M, et al. Non-selective beta-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis. J Gastroenterol. 2012;47(5):561–8.

    Article  CAS  PubMed  Google Scholar 

  114. Piecha F, Mandorfer M, Peccerella T, Ozga AK, Poth T, Vonbank A, et al. Pharmacological decrease of liver stiffness is pressure-related and predicts long-term clinical outcome. Am J Physiol Gastrointest Liver Physiol. 2018;315(4):G484–G94.

    Article  CAS  PubMed  Google Scholar 

  115. Kim HY, So YH, Kim W, Ahn DW, Jung YJ, Woo H, et al. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices. J Hepatol. 2019;70(3):412–22.

    Article  CAS  PubMed  Google Scholar 

  116. Novelli PM, Cho K, Rubin JM. Sonographic assessment of spleen stiffness before and after transjugular intrahepatic portosystemic shunt placement with or without concurrent embolization of portal systemic collateral veins in patients with cirrhosis and portal hypertension: a feasibility study. J Ultrasound Med. 2015;34(3):443–9.

    Article  PubMed  Google Scholar 

  117. Gao J, Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG. The stiffness of the liver and spleen on ARFI Imaging pre and post TIPS placement: a preliminary observation. Clin Imaging. 2012;36(2):135–41.

    Article  PubMed  Google Scholar 

  118. Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG, Chen J, et al. Spleen stiffness and splenoportal venous flow: assessment before and after transjugular intrahepatic portosystemic shunt placement. J Ultrasound Med. 2013;32(2):221–8.

    Article  PubMed  Google Scholar 

  119. Gao J, Zheng X, Zheng YY, Zuo GQ, Ran HT, Auh YH, et al. Shear wave elastography of the spleen for monitoring transjugular intrahepatic portosystemic shunt function: a pilot study. J Ultrasound Med. 2016;35(5):951–8.

    Article  PubMed  Google Scholar 

  120. De Santis A, Nardelli S, Bassanelli C, Lupo M, Iegri C, Di Ciesco CA, et al. Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt. J Gastroenterol Hepatol. 2018;33(3):704–9.

    Article  PubMed  Google Scholar 

  121. Buechter M, Manka P, Theysohn JM, Reinboldt M, Canbay A, Kahraman A. Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis. 2018;50(1):54–60.

    Article  PubMed  Google Scholar 

  122. Han H, Yang J, Zhuge YZ, Zhang M, Wu M. Point shear wave elastography to evaluate and monitor changing portal venous pressure in patients with decompensated cirrhosis. Ultrasound Med Biol. 2017;43(6):1134–40.

    Article  PubMed  Google Scholar 

  123. Tzschätzsch H, Sack I, Marticorena Garcia SR, Ipek-Ugay S, Braun J, Hamm B, et al. Time-harmonic elastography of the liver is sensitive to intrahepatic pressure gradient and liver decompression after transjugular intrahepatic portosystemic shunt (TIPS) implantation. Ultrasound Med Biol. 2017;43(3):595–600.

    Article  PubMed  Google Scholar 

  124. Attia D, Rodt T, Marquardt S, Hinrichs J, Meyer BC, Gebel M, et al. Shear wave elastography prior to transjugular intrahepatic portosystemic shunt may predict the decrease in hepatic vein pressure gradient. Abdom Radiol (NY). 2019;44(3):1127–34.

    Article  Google Scholar 

  125. Jansen C, Moller P, Meyer C, Kolbe CC, Bogs C, Pohlmann A, et al. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology. 2018;67(4):1472–84.

    Article  CAS  PubMed  Google Scholar 

  126. De Gottardi A, Rautou PE, Schouten J, Rubbia-Brandt L, Leebeek F, Trebicka J, et al. Porto-sinusoidal vascular disease: proposal and description of a novel entity. Lancet Gastroenterol Hepatol. 2019;4(5):399–411.

    Article  PubMed  Google Scholar 

  127. Khanna R, Sarin SK. Idiopathic portal hypertension and extrahepatic portal venous obstruction. Hepatol Int. 2018;12(S1):148–67.

    Article  PubMed  Google Scholar 

  128. Vuppalanchi R, Mathur K, Pyko M, Samala N, Chalasani N. Liver stiffness measurements in patients with noncirrhotic portal hypertension—the devil is in the details. Hepatology. 2018;68(6):2438–40.

    Article  PubMed  Google Scholar 

  129. Laharie D, Vergniol J, Bioulac-Sage P, Diris B, Poli J, Foucher J, et al. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver. Eur J Gastroenterol Hepatol. 2010;22(4):487–93.

    Article  PubMed  Google Scholar 

  130. Seijo S, Reverter E, Miquel R, Berzigotti A, Abraldes JG, Bosch J, et al. Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension. Dig Liver Dis. 2012;44(10):855–60.

    Article  PubMed  Google Scholar 

  131. Colecchia A, Ravaioli F, Sessa M, Alemanni VL, Dajti E, Marasco G, et al. Liver stiffness measurement allows early diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome in adult patients who undergo hematopoietic stem cell transplantation: results from a monocentric prospective study. Biol Blood Marrow Transplant. 2019;25(5):995–1003.

    Article  PubMed  Google Scholar 

  132. Sharma P, Mishra SR, Kumar M, Sharma BC, Sarin SK. Liver and spleen stiffness in patients with extrahepatic portal vein obstruction. Radiology. 2012;263(3):893–9.

    Article  PubMed  Google Scholar 

  133. Madhusudhan KS, Kilambi R, Shalimar SP, Sharma R, Srivastava DN, et al. Measurement of splenic stiffness by 2D-shear wave elastography in patients with extrahepatic portal vein obstruction. Br J Radiol. 2018;91(1092):20180401.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Dajti E, Ravaioli F, Colecchia A, Marasco G, Vestito A, Festi D. Liver and spleen stiffness measurements for assessment of portal hypertension severity in patients with Budd Chiari syndrome. Can J Gastroenterol Hepatol. 2019;2019:1673197.

    Article  PubMed  PubMed Central  Google Scholar 

  135. Mukund A, Pargewar SS, Desai SN, Rajesh S, Sarin SK. Changes in liver congestion in patients with Budd–Chiari syndrome following endovascular interventions: assessment with transient elastography. J Vasc Interv Radiol. 2017;28(5):683–7.

    Article  PubMed  Google Scholar 

  136. Wang HW, Shi HN, Cheng J, Xie F, Luo YK, Tang J. Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: a pilot study. PLoS One. 2018;13(5):e0197550.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  137. Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, et al. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis. Aliment Pharmacol Ther. 2008;28(9):1102–10.

    Article  CAS  PubMed  Google Scholar 

  138. Kawaguchi T, Sumida Y, Umemura A, Matsuo K, Takahashi M, Takamura T, et al. Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese. PLoS One. 2012;7(6):e38322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Sanchez-Conde M, Miralles P, Bellon JM, Rincon D, Ramirez M, Gutierrez I, et al. Use of transient elastography (FibroScan(R)) for the noninvasive assessment of portal hypertension in HIV/HCV-coinfected patients. J Viral Hepat. 2011;18(10):685–91.

    Article  CAS  PubMed  Google Scholar 

  140. Reiberger T, Ferlitsch A, Payer BA, Pinter M, Schwabl P, Stift J, et al. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography—a large single center experience. Wien Klin Wochenschr. 2012;124(11-12):395–402.

    Article  PubMed  Google Scholar 

  141. Hong WK, Kim MY, Baik SK, Shin SY, Kim JM, Kang YS, et al. The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data. Clin Mol Hepatol. 2013;19(4):370–5.

    Article  PubMed  PubMed Central  Google Scholar 

  142. Augustin S, Millan L, Gonzalez A, Martell M, Gelabert A, Segarra A, et al. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study. J Hepatol. 2014;60(3):561–9.

    Article  PubMed  Google Scholar 

  143. Schwabl P, Bota S, Salzl P, Mandorfer M, Payer BA, Ferlitsch A, et al. New reliability criteria for transient elastography increase the number of accurate measurements for screening of cirrhosis and portal hypertension. Liver Int. 2015;35(2):381–90.

    Article  PubMed  Google Scholar 

  144. Cho EJ, Kim MY, Lee JH, Lee IY, Lim YL, Choi DH, et al. Diagnostic and prognostic values of noninvasive predictors of portal hypertension in patients with alcoholic cirrhosis. PLoS One. 2015;10(7):e0133935.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  145. Zykus R, Jonaitis L, Petrenkiene V, Pranculis A, Kupcinskas L. Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study. BMC Gastroenterol. 2015;15:183.

    Article  PubMed  PubMed Central  Google Scholar 

  146. Hametner S, Ferlitsch A, Ferlitsch M, Etschmaier A, Schofl R, Ziachehabi A, et al. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a new marker for clinically significant portal hypertension in comparison to other non-invasive parameters of fibrosis including ELF test. PLoS One. 2016;11(2):e0149230.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  147. Kumar A, Khan NM, Anikhindi SA, Sharma P, Bansal N, Singla V, et al. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: a study of 326 patients from India. World J Gastroenterol. 2017;23(4):687–96.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Choi SY, Jeong WK, Kim Y, Kim J, Kim TY, Sohn JH. Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis. Radiology. 2014;273(3):917–26.

    Article  PubMed  Google Scholar 

  149. Kim TY, Jeong WK, Sohn JH, Kim J, Kim MY, Kim Y. Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients. Liver Int. 2015;35(11):2416–24.

    Article  PubMed  Google Scholar 

  150. Maruyama H, Kobayashi K, Kiyono S, Sekimoto T, Kanda T, Yokosuka O. Two-dimensional shear wave elastography with propagation-based reliability assessment for grading hepatic fibrosis and portal hypertension. J Hepatobiliary Pancreat Sci. 2016;23(9):595–602.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

Yuly P. Mendoza is supported by the Swiss Government Excellence Scholarship ESKAS-Nr: 2018.0666; Susana G. Rodrigues receives financial support from the Stiftung für Leberkrankheiten Bern.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Annalisa Berzigotti .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mendoza, Y.P., Murgia, G., Rodrigues, S.G., Delgado, M.G., Berzigotti, A. (2020). Liver and Spleen Stiffness to Predict Portal Hypertension and Its Complications. In: Mueller, S. (eds) Liver Elastography. Springer, Cham. https://doi.org/10.1007/978-3-030-40542-7_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-40542-7_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-40541-0

  • Online ISBN: 978-3-030-40542-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics